Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Aims: To describe contraception use and the prescription of drugs that are either not recommended in pregnancy or are potentially teratogenic by diabetes type in women of child‐bearing age. Methods: Retrospective, cross‐sectional chart review undertaken in 22 general practices in Warwickshire, UK. Demographic, anthropometric, medical history, medication and contraception data were extracted from women aged 14 to 49 years with pre‐existing diabetes. Independent sample t‐test, Mann–Whitney test and χ 2‐test were used to test for univariable associations and multiple logistic regression was used to adjust for confounders. Results: Four hundred and seventy eligible women were identified; the majority had a diagnosis of Type 2 diabetes (67%). Thirty‐six per cent and 64% of women with Type 1 and Type 2 diabetes, respectively, were prescribed drugs not recommended for use in pregnancy (P < 0.001). Less than half were using concomitant contraception (P < 0.001). No significant difference of contraception use was observed between women who were and were not taking drugs not recommended for use in pregnancy (40 vs. 41%, P = 0.4). Conclusions: Use of drugs not recommended during pregnancy in women with diabetes of child‐bearing age is common but is not associated with increased use of contraception. There is need to identify and overcome barriers to effective contraception use for this population group in order to facilitate optimal management of cardiovascular risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“concerns about the potential teratogenic effects of current and experimental treatments often lead to the exclusion of women of childbearing age from clinical trials [120], resulting in underrepresentation of this group in research.”
From Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions (2025) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246
Major congenital malformations after first-trimester exposure to ACE inhibitors
Cooper, W. O., Hernandez-Diaz, S., Arbogast, P. G., Dudley, J. A., Dyer, S., Gideon, P. S., Hall, K., & Ray, W. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055202 · Cited by 1,192
Characteristics of an Adult Population With Newly Diagnosed Type 2 Diabetes
Hillier, T. A., & Pedula, K. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1522 · Cited by 284
Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis
Gilbert, C., Valois, M., & Koren, G. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.098 · Cited by 274
Research works printed but not linked: 22
- 10.1016/j.pcd.2008.10.003 · DOI
- 10.1016/1056-8727(95)00080-1 · DOI · Paper page
- CEMACH, 2007, Diabetes in Pregnancy: Are We Providing the Best Care? Findings of a National Enquiry: England, Wales and Northern Ireland
- 10.1002/(SICI)1520-6661(200001/02)9:1<66::AID-MFM14>3.0.CO;2-# · doi:10.1002/(sici)1520-6661(200001/02)9:1<66::aid-mfm14>3.0.co;2-#
- 10.1136/bmj.321.7267.983 · DOI · Paper page
- 10.1056/NEJM200404083501524 · DOI · Paper page
- NICE, 2008, Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre‐conception to the Postnatal Period
- Abalos E, 2007, Antihypertensive drug therapy for mild to moderate hypertension during pregnancy, Cochrane Database Syst Rev, 1, CD002252
- 10.1111/j.1464-5491.2006.01856.x · DOI · Paper page
- Department of Health, 2001, National Service Framework for Diabetes (England) Standards
- Office of National Statistics, 2001 Census
- NICE, 2008, Type 2 Diabetes: the Management of Type 2 Diabetes. Clinical guideline CG66
- SPSS Base 7.5 for Windows, 1997, User's Guide
- 10.1136/bmj.39518.615058.AE · doi:10.1136/bmj.39518.615058.ae
- 10.1080/09513590600624317 · DOI
- 10.1177/0145721710365171 · DOI
- Chuang CH, Contraceptive use by diabetic and obese women, Womens Health Issues, 15, 167, 10.1016/j.whi.2005.04.002 · DOI
- 10.1097/01.AOG.0000216002.36799.b4 · DOI
- 10.1016/j.diabres.2004.07.020 · DOI
- 10.1111/j.1399-5448.2006.00197.x · DOI
- Pringle M, 1995, Assessment of the completeness and accuracy of computer medical records in four practices committed to recording data on computer, Br J Gen Pract, 45, 537
- 10.1186/1472-6874-10-5 · DOI
Cited by
Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions
Savage, M. J., Goldney, J., Slater, T., Sarkar, P., Sargeant, J. A., Wilmot, E. G., & Davies, M. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0561 · Cited by 11
Self-citation
Metadata
- Authors
- Makda, S. I., Davies, M. J., Wilmot, E., Bankart, J., Yates, T., Varghese, E. M., Fisher, H., Anwar, A., & Khunti, K.
- Affiliations
- East Midlands Healthcare Work Force Deanery University of Leicester Leicester
- Department of Cardiovascular Sciences
- Department of Health Sciences University of Leicester Leicester
- Department of Diabetes, University Hospitals Coventry And Warwickshire Warwickshire
- School of Social and Community Medicine University of Bristol Bristol
- Heart of England NHS Trust Birmingham UK
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2013-03-17
- Volume
- 30
- Issue
- 4
- Pages
- 457-463
- ISSN
- 0742-3071
- 1464-5491
- Cited by
- 14
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception. https://app.cochat.ai/papers/10.1111/dme.12051
- The paper
- Makda, S. I., Davies, M. J., Wilmot, E., Bankart, J., Yates, T., Varghese, E. M., Fisher, H., Anwar, A., & Khunti, K. (2013). Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception. Diabetic Medicine. https://doi.org/10.1111/dme.12051
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.